Concepedia

Josh Clayton

JC

Statistics

Publications

1

Citations

17

H-Index

1

Active since

2018

Affiliations

Eli Lilly (United States)(Current)

Josh Clayton is an author at Eli Lilly (United States) specializing in pharmacy, drug discovery, and drug design.

Publications per year

2018–2018

1

Publications

1

Discovery of chiral dihydropyridopyrimidinones as potent, selective and orally bioavailable inhibitors of AKT

Saravanan Parthasarathy, Kenneth J. Henry, Huaxing Pei et al. · Bioorganic & Medicinal Chemistry Letters · 2018 · 17 citations · Full text

, , +7

1–1 of 1